ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 204 filers reported holding ANACOR PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $6,746,000 | +9.9% | 126,216 | +132.3% | 0.01% | +33.3% |
| Q4 2015 | $6,138,000 | +125.5% | 54,335 | +135.0% | 0.01% | +200.0% |
| Q3 2015 | $2,722,000 | +377.5% | 23,125 | +214.0% | 0.00% | +100.0% |
| Q2 2015 | $570,000 | +6.3% | 7,365 | -20.5% | 0.00% | 0.0% |
| Q1 2015 | $536,000 | +13.3% | 9,269 | -36.7% | 0.00% | – |
| Q4 2014 | $473,000 | +1531.0% | 14,649 | +1118.7% | 0.00% | – |
| Q3 2014 | $29,000 | -32.6% | 1,202 | -50.3% | 0.00% | – |
| Q2 2014 | $43,000 | -69.7% | 2,417 | -66.0% | 0.00% | – |
| Q1 2014 | $142,000 | -22.4% | 7,103 | -35.1% | 0.00% | – |
| Q4 2013 | $183,000 | +120.5% | 10,945 | +40.1% | 0.00% | – |
| Q3 2013 | $83,000 | +822.2% | 7,814 | +383.5% | 0.00% | – |
| Q2 2013 | $9,000 | – | 1,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |